These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34363860)

  • 1. Drug release from in situ forming implants and advances in release testing.
    Wang X; Burgess DJ
    Adv Drug Deliv Rev; 2021 Nov; 178():113912. PubMed ID: 34363860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel adapter method for in vitro release testing of in situ forming implants.
    Wang X; Bao Q; Suh MS; Kastellorizios M; Wang R; Burgess DJ
    Int J Pharm; 2022 Jun; 621():121777. PubMed ID: 35489601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solvent induced phase inversion-based in situ forming controlled release drug delivery implants.
    Thakur RR; McMillan HL; Jones DS
    J Control Release; 2014 Feb; 176():8-23. PubMed ID: 24374003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards in vitro - In vivo correlation models for in situ forming drug implants.
    Wang X; Roy M; Wang R; Kwok O; Wang Y; Wang Y; Qin B; Burgess DJ
    J Control Release; 2024 Jun; 372():648-660. PubMed ID: 38936743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of implant formation on drug release kinetics of in situ forming implants.
    Suh MS; Kastellorizios M; Tipnis N; Zou Y; Wang Y; Choi S; Burgess DJ
    Int J Pharm; 2021 Jan; 592():120105. PubMed ID: 33232755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macroporous acrylamide phantoms improve prediction of in vivo performance of in situ forming implants.
    Hernandez C; Gawlik N; Goss M; Zhou H; Jeganathan S; Gilbert D; Exner AA
    J Control Release; 2016 Dec; 243():225-231. PubMed ID: 27742445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant monitoring of implant formation and drug release of in situ forming poly (lactide-co-glycolide acid) implants in a hydrogel matrix mimicking the subcutis using UV-vis imaging.
    Sun Y; Jensen H; Petersen NJ; Larsen SW; Østergaard J
    J Pharm Biomed Anal; 2018 Feb; 150():95-106. PubMed ID: 29216591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silica particles incorporated into PLGA-based in situ-forming implants exploit the dual advantage of sustained release and particulate delivery.
    Thalhauser S; Peterhoff D; Wagner R; Breunig M
    Eur J Pharm Biopharm; 2020 Nov; 156():1-10. PubMed ID: 32860903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation, Optimization and Physicochemical Characterization of Aripiprazole Loaded Nano-porous in situ Forming Implant.
    Hedayati A; Yazdi SG; Dehghankelishadi P; Javan NB; Akbari H; Dorkoosh FA
    Pharm Nanotechnol; 2017; 5(2):138-147. PubMed ID: 28530539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial Leuprolide Acetate Release from Poly(d,l-lactide-
    Li Z; Mu H; Larsen SW; Jensen H; Østergaard J
    Mol Pharm; 2020 Dec; 17(12):4522-4532. PubMed ID: 33164519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro - in vivo correlation: from theory to applications.
    Emami J
    J Pharm Pharm Sci; 2006; 9(2):169-89. PubMed ID: 16959187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perspectives on Physicochemical and In Vitro Profiling of Ophthalmic Ointments.
    Bao Q; Burgess DJ
    Pharm Res; 2018 Oct; 35(12):234. PubMed ID: 30324424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In situ forming implants for the delivery of metronidazole to periodontal pockets: formulation and drug release studies.
    Kilicarslan M; Koerber M; Bodmeier R
    Drug Dev Ind Pharm; 2014 May; 40(5):619-24. PubMed ID: 24369747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PLGA in situ implants formed by phase inversion: critical physicochemical parameters to modulate drug release.
    Parent M; Nouvel C; Koerber M; Sapin A; Maincent P; Boudier A
    J Control Release; 2013 Nov; 172(1):292-304. PubMed ID: 24001947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix systems for oral drug delivery: Formulations and drug release.
    Vasvári G; Kalmár J; Veres P; Vecsernyés M; Bácskay I; Fehér P; Ujhelyi Z; Haimhoffer Á; Rusznyák Á; Fenyvesi F; Váradi J
    Drug Discov Today Technol; 2018 Jul; 27():71-80. PubMed ID: 30103866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting in vivo behavior of injectable, in situ-forming drug-delivery systems.
    Hernandez C; Exner AA
    Ther Deliv; 2017 Jul; 8(7):479-483. PubMed ID: 28350230
    [No Abstract]   [Full Text] [Related]  

  • 17. Synthesis and Characterisation of Photocrosslinked poly(ethylene glycol) diacrylate Implants for Sustained Ocular Drug Delivery.
    McAvoy K; Jones D; Thakur RRS
    Pharm Res; 2018 Jan; 35(2):36. PubMed ID: 29368249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How to measure release from nanosized carriers?
    Nothnagel L; Wacker MG
    Eur J Pharm Sci; 2018 Jul; 120():199-211. PubMed ID: 29751101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of Biodegradable Injectable In situ Forming Implants for Sustained Release of Lornoxicam.
    Christian R; Thakkar V; Patel T; Gohel M; Baldaniya L; Shah P; Pandya T; Gandhi T
    Curr Drug Deliv; 2019; 16(1):66-78. PubMed ID: 30264681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Release rate determination from in situ gel forming PLGA implant: a novel 'shape-controlled basket in tube' method.
    Zhang Q; Fassihi R
    J Pharm Pharmacol; 2020 Aug; 72(8):1038-1048. PubMed ID: 32342528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.